Expression of α-synuclein, the precursor of non-amyloid β component of Alzheimer's disease amyloid, in human cerebral blood vessels

被引:56
|
作者
Tamo, W
Imaizumi, T [1 ]
Tanji, K
Yoshida, H
Mori, F
Yoshimoto, M
Takahashi, H
Fukuda, I
Wakabayashi, K
Satoh, K
机构
[1] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Mol Biol, Hirosaki, Aomori 0368562, Japan
[3] Taisho Pharmaceut Co Ltd, Med Res Labs, Mol Biol Lab, Omiya, Saitama 3308530, Japan
[4] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan
[5] Hirosaki Univ, Sch Med, Dept Surg 1, Hirosaki, Aomori 0368562, Japan
基金
日本学术振兴会;
关键词
alpha-synuclein; endothelial cells; smooth muscle cells; amyloid beta; non-amyloid beta component; precursor of non-amyloid beta component; Parkinson's disease; Alzheimer's disease;
D O I
10.1016/S0304-3940(02)00297-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The non-amyloid beta component of Alzheimer's disease amyloid (NAC) is detected in cerebral amyloid angiopathy; and the precursor of NAC is now known to be identical to alpha-synuclein (alpha-S), a major component of Lewy bodies in Parkinson's disease. We studied if cerebral vascular cells express alpha-S. Immunohistochemical studies of human cerebral tissues from control and cerebral amyloid angiopathy patients revealed the expression of alpha-S in vascular endothelial and smooth muscle cells. Then we studied the expression of alpha-S in vitro using cultures of vascular cells. Cultures of human umbilical vein endothelial cells and umbilical artery smooth muscle cells were found to constitutively express alpha-S messenger RNA and protein. alpha-S is normally expressed in vascular cells and may play some physiological role in the vascular wall. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 50 条
  • [41] Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid
    Paik, SR
    Lee, JH
    Kim, DH
    Chang, CS
    Kim, J
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 344 (02) : 325 - 334
  • [42] Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report
    Gauthier, S.
    Aisen, P. S.
    Cummings, J.
    Detke, M. J.
    Longo, F. M.
    Raman, R.
    Sabbagh, M.
    Schneider, L.
    Tanzi, R.
    Tariot, P.
    Weiner, M.
    Touchon, J.
    Vellas, B.
    Abushakra, Susan
    Alam, John
    Andrieu, Sandrine
    Bansal, Anu
    Baudler, Monika
    Bell, Joanne
    Beraud, Mickal
    Bittner, Tobias
    Haeberlein, Samantha Budd
    Bullain, Szofia
    Cantillon, Marc
    Carrillo, Maria
    Castrillo-Viguera, Carmen
    Cheung, Ivan
    Coelho, Julia
    Di Giusto, Daniel
    Doody, Rachelle
    Dwyer, John
    Egan, Michael
    Ewen, Colin
    Fisher, Charles
    Gold, Michael
    Hampel, Harald
    He, Ping
    Hendrix, Suzanne
    Henley, David
    Irizarry, Michael
    Iwata, Atsushi
    Iwatsubo, Takeshi
    Keeley, Michael
    Kerchner, Geoffrey
    Kinney, Gene
    Kolb, Hartmuth
    Kosco-Vilbois, Marie
    Kramer, Lynn
    Kurzman, Ricky
    Lannfelt, Lars
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 152 - 157
  • [43] EXPRESSION OF HUMAN ALZHEIMER AMYLOID PRECURSOR PROTEIN IN INSECT CELLS
    RAMAKRISHNA, N
    SAIKUMAR, P
    POTEMPSKA, A
    WISNIEWSKI, HM
    MILLER, DL
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 174 (02) : 983 - 989
  • [44] Implications of amyloid precursor protein and subsequent β-amyloid production to the pharmacotherapy of Alzheimer's disease
    Rojas-Fernandez, CH
    Chen, M
    Fernandez, HL
    PHARMACOTHERAPY, 2002, 22 (12): : 1547 - 1563
  • [45] Amyloid β interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease
    Alfredo Lorenzo
    Menglan Yuan
    Zhuohua Zhang
    Paolo A. Paganetti
    Christine Sturchler-Pierrat
    Matthias Staufenbiel
    Jorge Mautino
    Francisco Sol Vigo
    Bernd Sommer
    Bruce A. Yankner
    Nature Neuroscience, 2000, 3 : 460 - 464
  • [46] APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease
    Hohman, Timothy J.
    Dumitrescu, Logan
    Oksol, Amy
    Wagener, Madison
    Gifford, Katherine A.
    Jefferson, Angela L.
    PLOS ONE, 2017, 12 (11):
  • [47] Amyloid β interacts with the amyloid precursor protein:: a potential toxic mechanism in Alzheimer's disease
    Lorenzo, A
    Yuan, ML
    Zhang, ZH
    Paganetti, PA
    Sturchler-Pierrat, C
    Staufenbiel, M
    Mautino, J
    Sol Vigo, F
    Sommer, B
    Yankner, BA
    NATURE NEUROSCIENCE, 2000, 3 (05) : 460 - 464
  • [48] Hereditary Alzheimer's disease with amyloid angiopathy caused by amyloid precursor protein locus
    Axer, H.
    Huege, S.
    Wilhelm, C.
    Axer, M.
    Kunze, A.
    Reichenbach, J. R.
    Freesmeyer, M.
    Kohlhase, J.
    Sauer, H.
    Baer, K. -J.
    NERVENARZT, 2009, 80 (01): : 62 - +
  • [49] Spatial correlations between β-amyloid (Aβ) deposits and blood vessels in familial Alzheimer's disease
    Armstrong, Richard A.
    FOLIA NEUROPATHOLOGICA, 2008, 46 (04) : 241 - 248
  • [50] MicroRNA regulation of Alzheimer's Amyloid precursor protein expression
    Hebert, Sebastien S.
    Horre, Katrien
    Nicolai, Laura
    Bergmans, Bruno
    Papadopoulou, Aikaterini S.
    Delacourte, Andre
    De Strooper, Bart
    NEUROBIOLOGY OF DISEASE, 2009, 33 (03) : 422 - 428